Targeting therapeutic gene expression to human prostate cancers

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Current human carcinoma of the prostate therapies are largely palliative, not curative.
• A need exists for novel prostate cancer treatments derived from prostate biology.
• Extrapolation of treatments from other tumor types is insufficient for prostate cancer.

Purpose of the Study:

• To review various prostate targeting strategies for eliminating prostate carcinoma cells.
• To discuss targeting at the attachment, expression, and therapeutic gene levels.
• To highlight the necessity of a combination approach for optimal and safe prostate targeting.

Main Methods:

• Review of existing literature on prostate targeting strategies.
• Analysis of targeting at molecular and genetic levels.
• Evaluation of gene expression for prostate specificity.

Main Results:

• Prostate targeting can be achieved at attachment, expression, and therapeutic gene levels.
• Elimination of extraprostatic prostate carcinoma cells is a key objective.
• Few genes offer absolute prostate specificity, limiting single-target approaches.

Conclusions:

• A combination approach is essential for effective and safe prostate carcinoma targeting.
• Future therapies should leverage a deep understanding of prostate biology.
• Overcoming the challenge of prostate specificity is crucial for curative treatments.